CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY BENEFITS

3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.2.3. Top winning strategies

3.3. TOP PLAYER POSITIONING
3.4. PORTERS FIVE FORCE ANALYSIS
3.5. CORD BLOOD TRANSPLANT FOR TREATMENT OF MEDICAL CONDITIONS

3.5.1. Current scenario

3.5.1.1. Lymphomas
3.5.1.2. Leukemias
3.5.1.3. Transplants for inherited metabolic conditions
3.5.1.4. Transplants for inherited immunological disorders
3.5.1.5. Blood cell proliferation disorders

3.5.2. Future use (Clinical trials)

3.5.2.1. Neurologic Diseases
3.5.2.2. Auto-Immune Diseases
3.5.2.3. Orthopedic Diseases
3.5.2.4. Cardiovascular Diseases
3.5.2.5. Becker Muscular Dystrophy
3.5.2.6. Stem cells & gene therapy for inherited disorders
3.5.2.7. Stem Cells & Gene Therapy for Inherited Disorders
3.5.2.8. Stem Cell Transplantation for New Indications

3.6. REGULATORY SCENARIOS

3.6.1. FDA Biologics License Application (FDA BLA)
3.6.2. American Association of Blood Banks (AABB)
3.6.3. Clinical Laboratory Improvement Amendments (CLIA)
3.6.4. American Association of Tissue Banks (AATB)
3.6.5. Joint Accreditation Committee - ISCT - EBMT (JACIE)
3.6.6. Human Tissue Authority (HTA) - UK
3.6.7. Foundation for the Accreditation of Cellular Therapy (FACT)
3.6.8. International Organization for Standardization (ISO)
3.6.9. NetCord

3.7. MARKET DYNAMICS

3.7.1. Drivers

3.7.1.1. Increase in R&D activities for application of cord blood
3.7.1.2. Rise in funds for public storage
3.7.1.3. Increase in prevalence of fatal chronic diseases

3.7.2. Restraints

3.7.2.1. Legal and ethical issues during collection
3.7.2.2. Difficulty of finding a match in the donor list
3.7.2.3. High processing and storage cost for cord blood
3.7.2.4. Lack of awareness

3.7.3. Opportunities

3.7.3.1. Advancement in therapeutic application
3.7.3.2. Untapped opportunities in developing regions
3.7.3.3. Initiatives to spread awareness

CHAPTER 4 CORD BLOOD BANKING SERVICES MARKET, BY STORAGE SERVICES

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PUBLIC CORD BLOOD BANKS

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. PRIVATE CORD BLOOD BANKS

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

CHAPTER 5 CORD BLOOD BANKING SERVICES MARKET, BY GEOGRAPHY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast

5.2.3.1. U.S. market size and forecast
5.2.3.2. Canada market size and forecast
5.2.3.3. Mexico market size and forecast

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast

5.3.3.1. France market size and forecast
5.3.3.2. Germany market size and forecast
5.3.3.3. UK market size and forecast
5.3.3.4. Rest of Europe market size and forecast

5.4. ASIA-PACIFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast

5.4.3.1. Japan market size and forecast
5.4.3.2. China market size and forecast
5.4.3.3. India market size and forecast
5.4.3.4. Singapore market size and forecast
5.4.3.5. Malaysia market size and forecast
5.4.3.6. Thailand market size and forecast
5.4.3.7. Indonesia market size and forecast
5.4.3.8. Philippines market size and forecast
5.4.3.9. Hong Kong (including Macau) market size and forecast
5.4.3.10. South Korea market size and forecast
5.4.3.11. Rest of Asia-Pacific market size and forecast

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast

5.5.3.1. Latin America market size and forecast
5.5.3.2. Middle East and Africa market size and forecast
5.5.3.3. Rest of LAMEA market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1. AMAG PHARMACEUTICALS, INC.

6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Operating business segments
6.1.4. Product portfolio
6.1.5. Business performance
6.1.6. Key strategic moves and developments

6.2. AMERICORD REGISTRY LLC

6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Key strategic moves and developments

6.3. CHINA CORD BLOOD CORPORATION

6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Operating business segments
6.3.4. Business performance
6.3.5. Key strategic moves and developments

6.4. CORD BLOOD AMERICA, INC.

6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Operating business segments
6.4.4. Business performance
6.4.5. Key strategic moves and developments

6.5. CORDLIFE GROUP LIMITED

6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Operating business segments
6.5.4. Product portfolio
6.5.5. Business performance
6.5.6. Key strategic moves and developments

6.6. CORDVIDA

6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Operating business segments

6.7. CRYO-CELL INTERNATIONAL, INC.

6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Operating business segments
6.7.4. Product portfolio
6.7.5. Business performance

6.8. CRYOHOLDCO DE LATINOAMERICA, S.A.P.I. DE C.V.

6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Operating business segments

6.9. ESPERITE N.V.

6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Operating business segments
6.9.4. Product portfolio
6.9.5. Business performance

6.10. LIFEFORCE CRYOBANK SCIENCES, INC

6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Product portfolio

6.11. NATIONAL CORD BLOOD PROGRAM

6.11.1. Company overview
6.11.2. Company snapshot
6.11.3. Operating business segments

6.12. PERKINELMER, INC.

6.12.1. Company overview
6.12.2. Company snapshot
6.12.3. Operating business segments
6.12.4. Product portfolio
6.12.5. Business performance

6.13. VIRGIN GROUP LIMITED

6.13.1. Company overview
6.13.2. Company snapshot
6.13.3. Operating business segments
6.13.4. Product portfolio

6.14. VITA 34 AG

6.14.1. Company overview
6.14.2. Company snapshot
6.14.3. Operating business segments
6.14.4. Product portfolio
6.14.5. Business performance

List of Tables
TABLE 1. PUBLIC VS. PRIVATE CORD BLOOD BANK SERVICES
TABLE 2. GLOBAL CORD BLOOD BANKING SERVICES MARKET, BY STORAGE SERVICES, 2016-2023 ($MILLION)
TABLE 3. CORD BLOOD BANKING SERVICES MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 4. NORTH AMERICA CORD BLOOD BANKING SERVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 5. EUROPE CORD BLOOD BANKING SERVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 6. ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 7. LAMEA CORD BLOOD BANKING SERVICES MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 8. AMAG: COMPANY SNAPSHOT
TABLE 9. AMAG: PRODUCT CATEGORIES
TABLE 10. AMAG: PRODUCT PORTFOLIO
TABLE 11. AMERICORD: COMPANY SNAPSHOT
TABLE 12. AMERICORD: PRODUCT CATEGORIES
TABLE 13. AMERICORD: PRODUCT PORTFOLIO
TABLE 14. CCBC: COMPANY SNAPSHOT
TABLE 15. CCBC: PRODUCT CATEGORIES
TABLE 16. CBAI: COMPANY SNAPSHOT
TABLE 17. CBAI: PRODUCT CATEGORIES
TABLE 18. CORDLIFE: COMPANY SNAPSHOT
TABLE 19. CORDLIFE: OPERATING SEGMENTS
TABLE 20. CORDLIFE: PRODUCT PORTFOLIO
TABLE 21. CORDVIDA: COMPANY SNAPSHOT
TABLE 22. CORDVIDA: PRODUCT CATEGORY
TABLE 23. CRYO-CELL: COMPANY SNAPSHOT
TABLE 24. CRYO-CELL: OPERATING SEGMENTS
TABLE 25. CRYO-CELL: PRODUCT PORTFOLIO
TABLE 26. CRYOHOLDCO: COMPANY SNAPSHOT
TABLE 27. CRYOHOLDCO: PRODUCT CATEGORIES
TABLE 28. ESPERITE: COMPANY SNAPSHOT
TABLE 29. ESPERITE: OPERATING SEGMENTS
TABLE 30. ESPERITE: PRODUCT PORTFOLIO
TABLE 31. LIFEFORCE CRYOBANK: COMPANY SNAPSHOT
TABLE 32. LIFEFORCE CRYOBANK: PRODUCT PORTFOLIO
TABLE 33. NCBP: COMPANY SNAPSHOT
TABLE 34. NCBP: PRODUCT CATEGORY
TABLE 35. PERKINELMER: COMPANY SNAPSHOT
TABLE 36. PERKINELMER: OPERATING SEGMENTS
TABLE 37. PERKINELMER: PRODUCT PORTFOLIO
TABLE 38. VIRGIN: COMPANY SNAPSHOT
TABLE 39. VIRGIN: OPERATING SEGMENTS
TABLE 40. VIRGIN: PRODUCT PORTFOLIO
TABLE 41. VITA 34: COMPANY SNAPSHOT
TABLE 42. VITA 34: PRODUCT CATEGORIES
TABLE 43. VITA 34: PRODUCT PORTFOLIO

List of Figures
FIGURE 1. CORD BLOOD BANKING SERVICES MARKET SEGMENTATION
FIGURE 2. TOP IMPACTING FACTORS
FIGURE 3. TOP INVESTMENT POCKETS, BY REGION
FIGURE 4. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 5. GLOBAL CORD BLOOD BANKING SERVICES MARKET: TOP PLAYER POSITIONING
FIGURE 6. BARGAINING POWER OF BUYERS
FIGURE 7. BARGAINING POWER OF SUPPLIERS
FIGURE 8. THREAT OF SUBSTITUTION
FIGURE 9. THREAT OF NEW ENTRANT
FIGURE 10. COMPETITIVE RIVALRY
FIGURE 11. PUBLIC CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 12. PRIVATE CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 13. U.S. CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 14. CANADA CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 15. MEXICO CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 16. FRANCE CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 17. GERMANY CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 18. UK CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 19. REST OF EUROPE CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 20. JAPAN CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 21. CHINA CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 22. INDIA CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 23. SINGAPORE CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 24. MALAYSIA CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 25. THAILAND CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 26. INDONESIA CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 27. PHILIPPINES CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 28. HONG KONG (INCLUDING MACAU) CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 29. SOUTH KOREA CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 30. REST OF ASIA-PACIFIC CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 31. LATIN AMERICA CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 32. MIDDLE EAST AND AFRICA CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 33. REST OF LAMEA CORD BLOOD BANKING SERVICES MARKET, 2016-2023 ($MILLION)
FIGURE 34. AMAG: NET SALES, 2014-2016 ($MILLION)
FIGURE 35. CCBC: NET SALES, 2014-2016 ($MILLION)
FIGURE 36. CBAI: NET SALES, 2014-2016 ($MILLION)
FIGURE 37. CORDLIFE: NET SALES, 2014-2016 ($MILLION)
FIGURE 38. CORDLIFE: REVENUE BY PRODUCT, 2016 (%)
FIGURE 39. CORDLIFE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 40. CRYO-CELL: NET SALES, 2014-2016 ($MILLION)
FIGURE 41. CRYO-CELL: REVENUE BY PRODUCT, 2016 (%)
FIGURE 42. ESPERITE: NET SALES, 2014-2016 ($MILLION)
FIGURE 43. ESPERITE: REVENUE BY PRODUCT, 2016 (%)
FIGURE 44. ESPERITE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 45. PERKINELMER: NET SALES, 2014-2016 ($MILLION)
FIGURE 46. PERKINELMER: REVENUE BY SEGMENT, 2016 (%)
FIGURE 47. PERKINELMER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 48. VITA 34: NET SALES, 2014-2016 ($MILLION)
FIGURE 49. VITA 34: REVENUE BY GEOGRAPHY, 2016 (%)

Companies Profiled
China Cord Blood Corporation, Cord Blood America, Inc., CBR Systems, Inc., Cordlife Group Limited, Cryo-Cell International, Inc., Cryo-Save AG, Lifeforce Cryobanks, National Cord Blood Program, ViaCord, Inc., Virgin Health Bank, CordVida, Americord, CryoHoldco, and Vita34